Guinea pigs which have recovered from a genital infection with the agent of guinea pig inclusion conjunctivitis demonstrate strong immunity to reinfection for a short period of time but then become susceptible to reinfection. The secondary infection is markedly shortened in duration and decreased in intensity. Previous These data indicate that previously infected guinea pigs require both cell-mediated immunity and humoral immunity for resolution of a challenge infection.
Studies with patients infected in the genital tract with Chlamydia trachomatis have indicated that both humoral and cell-mediated immune (CMI) responses are activated (3, 6, 8) ; however, the role of these responses in the resolution of the infection and in resistance to a second exposure have yet to be determined. Previous studies with guinea pigs infected in the genital tract with the chlamydial agent of guinea pig inclusion conjunctivitis (GPIC), a member of the species Chiamydia psittaci, have demonstrated that both antibody and CMI are required for resolution of a primary infection. When humoral immunity was abrogated by treating guinea pigs with cyclophosphamide, leaving CMI intact, animals were unable to resolve the infection and maintained an elevated level of infection for the duration of the experiment (16) . When CMI was compromised prior to infection by treatment with anti-thymocyte serum (ATS), both serum and secretion antibodies developed and the infection accordingly decreased in intensity but did not resolve as long as ATS treatment was continued (13) .
The role of antibody has also been examined in resistance to and recovery from a challenge infection (12) . Guinea pigs deprived of humoral immunity by cyclophosphamide treatment were infected and then cured of the infection with tetracycline. Even though all of the animals had developed Chlamydia-specific CMI, they were still susceptible to reinfection when challenged by infection of the genital tract, indicating an important role for humoral immunity in resistance to reinfection. Moreover, the kinetics of the secondary * Corresponding author. infection in these immunologically compromised animals resembled that of a primary infection.
A recent study has indicated that complete resistance to reinfection in immunologically intact guinea pigs is relatively short-lived and that animals become reinfected when challenged as soon as 8 weeks after resolution of the primary infection (15) . In this study, when the animals became reinfected, the course of the challenge infection was abbreviated and markedly lower in intensity, indicating that the animals did possess a significant degree of immunity. Thus, in the present study, we wanted to determine the extent, if any, to which this immunity was dependent upon CMI. To do this, female guinea pigs were infected in the genital tract with GPIC and were allowed to develop normal serum and secretion antibody responses as well as a normal CMI response. At either 30 or 75 days after resolution of the infection, animals were deprived of CMI by treatment with ATS, challenged with a fresh inoculum of GPIC, and then monitored for the course of the challenge infection.
MATERIALS AND METHODS
Experimental animals. Female Hartley strain guinea pigs, weighing 450 to 500 g, were obtained from Sasco Laboratories, Omaha, Nebr. All animals were housed individually in cages covered with fiber glass filters and were given food and water ad libitum. The room lighting was maintained on a 12 h light/12 h dark cycle.
Infection of guinea pigs with chlamydiae. GPIC for infection was grown in McCoy cell cultures (7) . Portions of host cell-free chlamydiae were frozen in sucrose-phosphate CELL-MEDIATED IMMUNITY IN CHLAMYDIAL GENITAL INFECTION buffer (2-SP) at -70°C until needed. Animals were infected by intravaginal inoculation with 0.05 ml of the GPIC suspension, which contained 1.3 x 107 (day 30) or 6.4 x 106 (day 75) inclusion-forming units (15) . Animals were monitored for the course of the infection by assessing the number of chlamydial inclusions on a vaginal scraping stained with Giemsa and by the isolation of organisms in cell cultures from cervical swabs (15) . The cultures were not quantitated but were merely scored as positive or negative for chlamydiae. The latter method has been found to be the more sensitive of the two assay systems (15) . Whenever an animal was found to be positive as a result of the detection of GPIC on a vaginal scraping, that animal was always isolation positive. However, chlamydiae were commonly detected by isolation in the presence of a negative scraping.
Treatment with ATS. ATS was produced by immunizing New Zealand White rabbits intradermally with newborn guinea pig thymocytes as previously described (13) . The rabbits were initially injected intradermally with 5 x 107 thymocytes in Freund complete adjuvant and were given similar injections 2 weeks later. The animals were given two intravenous inoculations at 2-week intervals. Antiserum obtained from the rabbits was pooled, inactivated at 56°C for 30 min, and then absorbed four times with 10% washed guinea pig erythrocytes. Normal rabbit serum (NRS) (Hazelton Research Products, Inc., Lenexa, Kans.) was also heat inactivated and determined to be free of anti-guinea pig erythrocyte antibodies by hemagglutination. The sera were filter sterilized through 0.45-,um-pore-size filters.
Guinea pigs were injected daily with 1 ml of either ATS or NRS beginning 1 day prior to reinfection with GPIC. The treatment was continued for the duration of the experiment. The effectiveness of ATS treatment was assessed in all animals by sensitization and subsequent challenge with oxazolone and on selected groups by the proliferative response of peripheral blood mononuclear cells to GPIC antigen and concanavalin A (ConA).
Determination of antibody levels. Sera and genital secretions were obtained from guinea pigs as previously described (12, 16) and stored at -20°C until all specimens in the experiment were collected. Serum immunoglobulin G (IgG) was measured by an enzyme-linked immunosorbent assay using HeLa-grown GPIC elementary bodies as antigen and peroxidase-labeled rabbit anti-guinea pig IgG (heavy and light chain specific) (ICN ImmunoBiologicals, Lisle, Ill.) (14) . IgA in genital secretions was determined by a similar assay, except that rabbit anti-guinea pig IgA (a chain specific) (ICN) was used, followed by peroxidase-labeled goat anti-rabbit IgG (heavy and light chain specific) (ICN) (14) .
Immunoblot analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electrophoretic transfer of chlamydial proteins to nitrocellulose membranes, and immunoblotting assays were performed as previously described (2) . Blocking of nitrocellulose membranes was accomplished by using a solution of 150 mM NaCl-10 mM Tris-0.5% (wt/vol) nonfat dry milk (Carnation), pH 7.4. Guinea pig serum specimens were diluted 1:500 to 1:1,000. Vaginal secretions were diluted 1:40 in assays for IgA. In cases in which a sufficient volume of secretion was not available, the entire sample was used for the IgA assay (maximum dilution, 1:80). Localization of antibody binding was accomplished by using rabbit anti-guinea pig IgG (heavy and light chain specific) or IgA (a chain specific) (Miles Laboratories, Inc., Naperville, Ill.), followed by radioiodinated goat anti-rabbit IgG (Organon Teknika, Malvern, Pa.) and autoradiography.
Determination of CMI response. All animals were sensitized with the contact allergen oxazolone (4-ethoxymethylene-2-phenyl oxazolone) about 1 week prior to initiation of ATS and NRS treatment and were tested for their response to challenge 1 week after treatment began. The animals were sensitized on the ear and challenged on a shaved flank as previously described (16 (Fig. 1) . Once again, most of the ATS-treated guinea pigs remained infected for the course of the infection (7 of 10), whereas most of the animals in the control groups resolved their infections by day 12 (12 of 14) . The course of infection in the ATS-treated group was again significantly different from that in the NRS-treated group (P < 0.04). The level of infection in all groups was consistently low, as evidenced by negative findings on stained vaginal scrapings.
CMI. To define the effects of ATS treatment on guinea pig immune reactivity, animals were assessed for specific (GPIC) and nonspecific (ConA) blastogenesis and for delayed-type hypersensitivity to oxazolone. The results of these assays from the animals challenged on day 30 are shown in Fig. 2 and are representative of the reactions of all corresponding animals in the two experiments. ATS-treated guinea pigs routinely had a profound deficiency in both parameters of CMI tested, whereas NRS-treated and NT animals had normal responses. The delayed-type hypersensitivity responses of the ATS-treated animals were found to be significantly different from those in the NRS-treated and NT groups by the Mann-Whitney U test (P < 0.05). Proliferative responses of ATS-treated animals were also significantly lower than those in either of the control groups when assessed by a one-tailed t test (P < 0.005 for both GPIC antigen and ConA).
Humoral immune response. The antibody levels in serum and in genital secretions resulting from GPIC were also measured immediately prior to treatment and reinfection and then were measured again 14 days later to ascertain whether the prolongation of the secondary infection in the ATStreated group might have been a result of a reduced or absent anamnestic antibody response (Fig. 3) . No significant decreases in antibody titers in either serum or secretions were noted in either of the ATS-treated groups (one-tailed t test). The serum IgG titer of the ATS-treated group and the secretion IgA titer of the NT group following the day 75 challenge infection increased significantly (P < 0.05 and P < 0.005, respectively). There was also a significant decrease in the serum titer of the NRS-treated group after the day 30 challenge. These data indicated that ATS had no obvious effect on the antibody response as measured by enzymelinked immunosorbent assay .
To evaluate potential effects of ATS on the antigenspecific antibody responses, immunoblot analyses were performed on the prechallenge and day 14 postchallenge sera and genital secretions. Prechallenge sera (data not shown) from animals that were challenged at days 30 and 75 showed IgG responses to, among others, the major outer membrane protein, 61-kilodalton (kDa), 84-kDa, and lipopolysaccharide components that were similar to those we had previously observed (15 The secretion IgA response 14 days after challenge infection in both the ATS-and NRS-treated groups for animals in the second experiment are shown in Fig. 4 In an earlier study, when antibody-deficient but CMI-sufficient animals were challenged 28 days after a primary infection, the course of the secondary infection resembled that of the primary infection in intensity (12) . Thus, it would appear that antibody is able to diminish the number of organisms but is unable to completely eliminate them.
While we did not examine tissues by histopathology prior to challenge infection, we did study tissues from animals 7 days after the challenge infection to determine whether ATS affected the degree of mononuclear infiltration of the genital tract. While the mononuclear infiltrates in the genital tract were somewhat decreased in ATS-treated animals 1 week after challenge, a strong association between this phenomenon and extended infection cannot be drawn at this point. We have previously demonstrated that the appearance of a mononuclear population in the submucosa occurs at about the time that the infection begins to decrease in intensity (1) .
While these studies demonstrate that CMI is necessary to resolve a challenge infection in animals having previously recovered from a genital tract infection, the mechanism by which this resolution occurs is still not clear. It is unlikely that cytotoxic lymphocytes play a major role since they have not been documented to have activity against chlamydiainfected cells (9, 10) . Similarly, clearance of organisms by activated macrophages can be ruled out on the basis of the general lack of macrophages in contact with chlamydiae on the genital mucosal surface (1) . A more likely possibility is that gamma interferon or other cytokines produced by T cells are able to inhibit the growth of chlamydiae intracellularly or to destroy infected cells, as has been demonstrated in vitro (4, 5) . More recently, depletion of gamma interferon by treatment of mice with specific anti-murine gamma interferon antibody has resulted in enhanced respiratory infection with the mouse pneumonitis agent (18) . Whether this mechanism also occurs in genital tract infections remains to be determined.
